The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of contemporary practice patterns in the management of IDH-mutant glioma: A multidisciplinary multi-institutional survey.
 
L. Nicolas Gonzalez Castro
Stock and Other Ownership Interests - Takeda (I)
Honoraria - BMJ publishing; Elsevier; Medscape; Oakstone Publishing; Prime Education
Consulting or Advisory Role - SERVIER
Research Funding - Genentech; Merck
 
Tyler Lanman
No Relationships to Disclose
 
Haley Perlow
Consulting or Advisory Role - Novocure
 
Gilbert Youssef
No Relationships to Disclose
 
Roy Strowd
Consulting or Advisory Role - Alexion Pharmaceuticals; Monteris Medical; Monteris Medical; Novocure; SpringWorks Therapeutics
Research Funding - Alpha Omega Alpha; American Board of Psychiatry and Neurology; Jazz Pharmaceuticals; NIH; Southeastern Brain Tumor Foundation
Patents, Royalties, Other Intellectual Property - Elsevier, book royalties; Lecturio, lecture royalties
Other Relationship - American Academy of Neurology (AAN)
 
Michael Milano
Honoraria - Wolters Kluwer
Consulting or Advisory Role - Alexion Pharmaceuticals; Deciphera; Nuvation Bio; SERVIER; Telix Pharmaceuticals
 
Marina Kushnirsky
No Relationships to Disclose
 
Ankush Bhatia
Consulting or Advisory Role - Alexion Pharmaceuticals; Nuvation Bio; SERVIER; Telix Pharmaceuticals
 
Patrick Wen
Consulting or Advisory Role - Alexion Pharmaceuticals; Alexion Pharmaceuticals; AstraZeneca; Bayer; Black Diamond Therapeutics; Bristol Myers Squibb Foundation; Chimerix; Chimerix; Day One Biopharmaceuticals; Fore Biotherapeutics; Genenta Science; GlaxoSmithKline; ImVax; Merck; Nerviano Medical Sciences; Novocure; Nuvation Bio; Rigel; Sapience Therapeutics; Servier; Servier; SymBio Pharmaceuticals; Telix Pharmaceuticals
Research Funding - AstraZeneca (Inst); Bayer (Inst); Black Damond (Inst); Bristol-Myers Squibb/Medarex (Inst); Chimerix (Inst); Erasca, Inc (Inst); Erasca, Inc (Inst); Global Coalition for Adaptive Research (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Philogen (Inst); Quadriga Biosciences (Inst); Servier (Inst)
 
Julie Miller
Consulting or Advisory Role - SERVIER
 
Benjamin Rich
No Relationships to Disclose